47 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Novartis To Initiate Hydroxychloroquine Study for Coronavirus http://www.zacks.com/stock/news/880449/novartis-to-initiate-hydroxychloroquine-study-for-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880449 Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Incyte Gets FDA Nod for Cholangiocarcinoma Drug Pemazyre http://www.zacks.com/stock/news/880319/incyte-gets-fda-nod-for-cholangiocarcinoma-drug-pemazyre?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880319 Apr 20, 2020 - Incyte (INCY) gets FDA approval for Pemazyre for the treatment of previously-treated, unresectable, locally-advanced or metastatic cholangiocarcinoma.
Schlumberger NV (SLB) Q1 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/04/17/schlumberger-nv-slb-q1-2020-earnings-call-transcri.aspx?source=iedfolrf0000001 Apr 17, 2020 - SLB earnings call for the period ending March 31, 2020.
ASML HOLDING NV (ASML) Q1 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/04/15/asml-holding-nv-asml-q1-2020-earnings-call-transcr.aspx?source=iedfolrf0000001 Apr 15, 2020 - ASML earnings call for the period ending March 29, 2020.
TomTom NV (TMOAF) CEO Harold Goddijn on Q1 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4337739-tomtom-nv-tmoaf-ceo-harold-goddijn-on-q1-2020-results-earnings-call-transcript?source=feed_sector_transcripts Apr 15, 2020 - TomTom NV (OTCPK:TMOAF) Q1 2020 Results Earnings Conference Call April 15, 2020 08:00 AM ET Company Participants Claudia Janssen - Head, IR Harold Goddijn - CEO Taco Titulaer - CFO Conference Call Par
Tomtom NV 2020 Q1 - Results - Earnings Call Presentation https://seekingalpha.com/article/4337652-tomtom-nv-2020-q1-results-earnings-call-presentation?source=feed_all_articles Apr 15, 2020 - The following slide deck was published by Tomtom NV in conjunction with their 2020 Q1 earnings call.
Bausch (BHC) Starts Study on Virazole for Coronavirus Infection http://www.zacks.com/stock/news/870392/bausch-bhc-starts-study-on-virazole-for-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-870392 Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Roche's NDA for SMA Drug Gets Expanded Review From FDA http://www.zacks.com/stock/news/861186/roches-nda-for-sma-drug-gets-expanded-review-from-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-861186 Apr 08, 2020 - The FDA stretches the review timeline of Roche's (RHHBY) NDA for risdiplam by three months, which is being evaluated to treat spinal muscular atrophy. A decision is now pending on Aug 24, 2020.
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545 Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM http://www.zacks.com/stock/news/858931/the-zacks-analyst-blog-highlights-johnson-johnson-merck-co-novartis-paypal-and-ibm?cid=CS-ZC-FT-press_releases-858931 Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM

Pages: 12345

<<<Page 4